Table 3 Basic information, characteristics and outcomes from single-arm studies.
Author | Year | Design | Primary or salvage | Patients | Basic information | Results (%) | Mean follow-up (months) | Complications (%) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
OS | DSS | bDFS | Overall | Urinary | ED | |||||||
Pisters et al.20 | 1999 | R | Salvage | 145 | 5, 6, 7, 8, 10 | – | – | 55.2 | >6 | – | – | – |
De La Taille et al.21 | 2000 | P | Both | 35 | 1, 2, 5, 6, 7, 10 | 100 | 100 | 70(9 months) | 8.3 | – | >8.6 | – |
Izawa et al.22 | 2002 | R | Salvage | 131 | 5, 6, 7, 8, | 73(5 yrs) | 79(5 yrs) | 40(5 yrs) | 57.6 | – | ||
Bahn et al.23 | 2002 | R | Primary | 590 | 1, 2, 5, 6, 7, 8, 10 | – | 89.5(7 yrs) | 65.2 | – | >15.9 | 56.8 increased | |
Prepelica et al.24 | 2005 | R | Primary | 65 | 1, 2, 5, 6, 7, 9, 10 | 100 | 100 | 83.3 | 35 | – | – | – |
Bahn et al.25 | 2006 | R | Primary | 31 | 1, 2, 6, 7 | 96.8 | 100 | 92.9 | 70 | – | – | 11.1(potency preservation) |
Ellis et al.26 | 2007 | NA | Primary | 416 | 1, 5, 6, 7, 8, 9 | – | – | 79.6(4 yrs) | 20.4 | – | – | – |
Ismail et al.27 | 2007 | P | salvage | 100 | 1, 2, 5, 6, 7, 8, 9, 10 | – | 100 | 83%(1 yr); 72%(2 yrs); 59%(3 yrs); 25%(5 yrs) | 33.5 | – | >16 | 86 |
Ng et al.28 | 2007 | R | Salvage | 187 | 1, 5, 6, 7, 8, 10 | 97 (5 yrs); 92 (8 yrs) | – | 51 | 39 | – | >39 | – |
Diblasio et al.29 | 2008 | R | Primary | 78 | 1, 3, 4, 5, 6, 7, 8, 10 | 95.9%(1 yr); 94.3(3 yrs); 94.3(5 yrs) | 100 | 97.9%(1 yr); 82.9%(3 yrs); 82.9(5 yrs) | 39.8 | – | 41 increased | 33.4 increased for erectile function of 3 level and higher |
Jones et al.30 | 2008 | R | Primary | 77 | 1, 2, 6, 7 | – | – | 44.6 | 39.0 | – | – | – |
Truesdale et al.31 | 2010 | R | Primary | 77 | 1,4, 6, 7, 8, 9, | – | – | 72.7 | 24 | – | Decreased scores according to AUA SI and IIEF-5, respectively | |
Williams et al.32 | 2011 | R | Salvage | 176 | 1, 5, 6, 7, 8, 10 | 95(5 yrs); 91(8 yrs); 87(10 yrs) | – | 47(5 yrs); 39(8 yrs); 39(10 yrs) | 89.5 | – | – | – |
Caso et al.33 | 2012 | R | Primary | 97 | 1, 2, 4, 5, 6, 7, 8 | – | – | Biopsy: 87.6 | 48 | – | – | – |
Kim et al.34 | 2012 | R | Primary | 10 | 1, 6, 7, 9 | 100 | 100 | 100 | 13 | – | >30 | – |
Castro Abreu et al.35 | 2013 | R | Salvage | 50 | 1, 6, 7, 8, 10 | 100 | 100 | 78 (5 yrs) | >31 | – | – | – |
Durand et al.36 | 2013 | P | Primary | 48 | 1, 2, 3, 6, 7, 8, 9, 10 | 100 | 100 | Biopsy: 84 | 13.2 | 19 | No significantdecreased | Significant decrease in 3 months but in 6 months |
Al Ekish et al.37 | 2013 | R | Both | 30 | 1, 2, 6, 7, 9, 10 | 100 | 100 | 93.3 | 18 | – | – | – |
Hale et al.38 | 2013 | R | Primary | 26 | 1, 2, 4, 6, 7, 8 | 100 | 100 | 88.5 | 19.1 | – | – | 27 increased |
Ullal et al.39 | 2013 | R | Both | 32 | 1, 6, 7 | – | – | 68.8 | 41.2 | – | – | – |
Li et al.40 | 2014 | R | Salvage | 91 | 1, 2, 6, 7, 8, 10 | 98.9(5 yrs) | – | 95.3(1 yr); 72.4(3 yrs); 46.5(5 yrs) | 15 | – | >6.6 | 11.0 increased |
Guo et al.41 | 2014 | R | Primary | 75 | 1, 2, 5, 6, 7, 8, 9 | 85.3(5 yrs) | 92.0(5 yrs) | 48(5 yrs) | 75 | – | – | – |
Rodríguez et al.42 | 2014 | P | Primary | 102 | 1, 5, 6, 7, 8, 9, 10 | 94.4 | 98.1 | 76.9 | 61 | >11.1 | >5.6 | 32.1 increased |
Kvorning Ternov et al.43 | 2014 | R | Salvage | 30 | 1, 2, 6, 7, 8, 9, 10 | 93.3 | 96.7 | 43.5 | 32.4 | 16.7 for grade 3 and 4 | >53.3 | 100 |
Chang et al.44 | 2014 | R | Salvage | 12 | 1, 2, 6, 7, 8, 10 | – | 100 | 58.3 | 33 | – | 16.7 | 16.7 |
Elshafei et al.45 | 2015 | R | Primary | 2242 | 1, 2, 4, 5, 7, 8, 9 | – | – | 72.8(5yrs) | 32.6 | – | – | – |
Tay et al.46 | 2016 | R | Primary | 300 | 1, 2, 6, 7, 8, 9, 10 | 96.7 | – | 77.2(2yrs), 59.1(5yrs) | 28.4 | – | >9.7 | 83.5 |
Lian et al.47 | 2016 | R | Primary | 40 | 1, 2, 5, 6, 7, 8, 9, 10 | 100 | 100 | 95 | 63 | – | – | 36.6 |
